40% increase in production in Samen Pharmaceutical Company in 2024

Samen company was established in 1363 in order to meet the pharmaceutical needs of the country and was put into operation in Mashhad in 1371. Currently, this company is one of the largest pharmaceutical factories in the country with more than three decades of experience and has the possibility of producing 95 products in different pharmaceutical categories in the light of the support of the King of Hazrat Reza (AS), 47 of which are produced for the first time in the country. has been Meanwhile, the production of bottled and bagged serums in different volumes is one of its most important strategic products. In the following, we will have a conversation with Engineer Majid Tabasi, CEO of Samen Pharmaceutical Company, about the performance of this company in 1402.

With what approach did this company pursue its activities this year?
Samen Pharmaceutical Company has focused its activities in 1402 on increasing production, investing in the direction of sustainable development, participating and supporting knowledge-based companies in Samen Health Campus, improving the quality of bag products, responding to special patients and developing the company’s brand through attending exhibitions. , scientific congresses and… followed.

What measures has Samen taken to achieve these goals?
Among the most important measures of Samen Pharmaceuticals this year are the management of working capital in economic conditions to meet the needs of the health and medical community in a timely manner, numerous consultations with distribution companies, suppliers and the Ministry of Health, Treatment and Medical Education of the country, obtaining the necessary permits to He pointed out that the purpose is to speed up the activities of the Saman Health Campus and the companies based in the campus, as well as attracting domestic and foreign investors. In addition to carrying out the necessary activities in order to obtain licenses for several new products, other measures such as the launch of Niki Sam Pharma to produce products with high added value (types of eye drops), the launch and acquisition of licenses for animal injectable products, the use of reverse engineering in production line systems for The withdrawal of foreign currency has been prevented.

What about the development and renovation of Samen pharmaceutical factory? What programs have been followed this year?
For this purpose, in addition to improving and renovating the cleanrooms, the Safepack machine was added to the company’s production lines. Also, the necessary action was taken with the space development approach for the knowledge-based companies of the company’s sub-category.

What achievements have these measures brought to Samen Pharmaceuticals in the field of production and supply of products?
This year, this company managed to increase its production by 40% by launching a new serum bottle production line. Also, four new products were formulated by its research and development unit. The development of the product portfolio and cooperation with new and numerous broadcasting companies and the launch of the production line of animal injectable products were among the other achievements of this field this year.

In what areas did this group develop its product portfolio this year?
Samen Company followed up the development of peritoneal dialysis product portfolio, Cystic Fibrosis (CF) patient product portfolio, painkiller and anesthetic drugs portfolio, as well as open heart surgery solutions this year. Acquiring the technical knowledge of eye drop products was one of the other valuable actions of the company’s research and development unit.

What has been the success of Saman Pharmaceuticals in the field of job creation?
Currently, more than 700 people are directly working in this company, which number reaches about 800 people with the active forces in the companies under the cover of Samen Health Campus. Also, the production activities of Samen Pharmaceuticals have provided indirect job creation for more than three thousand people in the country.

What activities has this company done this year in order to introduce its products and also to expand its interactions with active institutions in the field of health, especially the medical community of the country?
For this purpose, every year Samen Pharmaceuticals with a number of its managers and experts participates in various international exhibitions and congresses, as this year also in various international exhibitions such as medicine and related industries (Iran Pharma), knowledge-based health in Tehran, as well as medical equipment in Mashhad and exhibitions International Uzbekistan, Moscow and Arab Health participated. In addition, Saman company participated in the exhibition section of two international congresses of the Lung Association and the Nephrology Association of the country. In the meantime, the Saman company participates in international exhibitions and negotiates with neighboring countries in order to export its products and benefit from and recognize the experiences and technologies of the world. In addition to these activities, this company has honored the services of the medical staff on various occasions such as Pharmacist Day, Doctor’s Day and Nurse’s Day by attending various medical centers.

This year, by using the capacities of Samen Health Technology Campus, what kind of support was given to technological and knowledge-based companies?
In response to this question, first of all, it should be said that Saman Health Campus is the first private health campus in the country, which was established with the participation of Khorasan Science and Technology Park. This campus has defined its field of activity in five fields, including injectable drugs, recombinant drugs, inhaled drugs, health and food equipment, and health promoters, and by supporting technological and knowledge-based companies in the health field, while supporting knowledge-based companies in the health field, It has provided the basis for investment and the presence of scientists and researchers from other countries. This year also witnessed significant actions such as establishing and increasing the production of blood collection tubes in Aron Life Page Company, establishing Niki Sam Pharma and preparing for the production of eye drops, establishing Khazar Multi-Layered Wrappers in a new location with a focus on the production of multi-layered wraps, establishing and supporting From Soba Fanavor Yekta Company in order to build bottle production machines and conclude new partnership contracts in the direction of producing all kinds of injectable fillers, medicines.